ENDO INTERNATIONAL for ENDO INTERNATIONAL
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research H.R. 523/S. 232--Protect Medical Innovation Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Copyright/Patent/Trademark CPT
Oversight of implementation of the America Invents Act Issues relating to patent settlements Legislation relating to abusive patent litigation
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Health Issues HCR
Issues relating to bioequivalence and related administrative procedures Issues relating to prescription drug abuse Issues relating to incentives for tamper-resistant formulations H.R. 486--Stop Tampering of Prescription Pills Act of 2013Issues relating to Medicare Part D rebates Issues relating to health information technology H.R. 1919 -- Safeguarding America's Pharmaceuticals Act of 2013 H.R. 3204 -- Compounding and drug supply chain legislation H.R. 984 -- Urotrauma legislation U.S. Preventive Services Task Force recommendations on PSA testing for prostate cancer
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRENT J FISK | — |
| JAMES BRIAN MUNROE | — |
| CANDIE PHIPPS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.